Schobel Alexander Mark Insider Trading
Get the latest insider transactions of Schobel Alexander Mark. Schobel Alexander Mark is Chief Innovation/Tech Officer in Aquestive Therapeutics, Inc. ($AQST) and SVP,Chief Innov/Tech Officer in Aquestive Therapeutics, Inc. ($AQST). Discover the current value of Schobel Alexander Mark shares.
Address: C/O AQUESTIVE THERAPEUTICS, INC. 30 TECHNOLOGY DRIVE WARREN 07059NJ
Schobel Alexander Mark is Insider in these Companies
Ticker | Company Name | Current and Previous Positions | Total Shares | Current Value ($) |
---|---|---|---|---|
AQST | Aquestive Therapeutics, Inc. | SVP,Chief Innov/Tech Officer, Chief Innovation/Tech Officer | 860,460 |
Insider Trading Transactions of Schobel Alexander Mark
Date | Ticker | Company | Owner | Relationship | Transaction | Cost ($) | Shares | Transaction Value ($) | Total Shares |
---|---|---|---|---|---|---|---|---|---|
Feb 10 2021 | AQST | Aquestive Therapeutics, I ... | Schobel Alexander Mark | Chief Innovation/Tech ... | Sell | 6.75 | 11,540 | 77,895 | 860,460 |
Feb 10 2021 | AQST | Aquestive Therapeutics, I ... | Schobel Alexander Mark | Chief Innovation/Tech ... | Sell | 6.75 | 23,460 | 158,355 | 837,000 |
Feb 09 2021 | AQST | Aquestive Therapeutics, I ... | Schobel Alexander Mark | Chief Innovation/Tech ... | Sell | 6.50 | 40,792 | 265,148 | 872,000 |
Jun 02 2020 | AQST | Aquestive Therapeutics, I ... | Schobel Alexander Mark | Chief Innovation/Tech ... | Buy | 0.00 | 14,572 | 0 | 916,685 |
Jun 02 2020 | AQST | Aquestive Therapeutics, I ... | Schobel Alexander Mark | Chief Innovation/Tech ... | Sell | 4.87 | 4,132 | 20,123 | 912,553 |
Jun 02 2020 | AQST | Aquestive Therapeutics, I ... | Schobel Alexander Mark | Chief Innovation/Tech ... | Option Exercise | 0.00 | 14,572 | 0 | 0 |
May 04 2020 | AQST | Aquestive Therapeutics, I ... | Schobel Alexander Mark | Chief Innovation/Tech ... | Sell | 3.70 | 40,000 | 148,000 | 982,113 |
May 04 2020 | AQST | Aquestive Therapeutics, I ... | Schobel Alexander Mark | Chief Innovation/Tech ... | Sell | 4.00 | 40,000 | 160,000 | 942,113 |
May 01 2020 | AQST | Aquestive Therapeutics, I ... | Schobel Alexander Mark | Chief Innovation/Tech ... | Sell | 4.50 | 40,000 | 180,000 | 1,022,113 |
Apr 02 2020 | AQST | Aquestive Therapeutics, I ... | Schobel Alexander Mark | Chief Innovation/Tech ... | Buy | 0.00 | 329 | 0 | 1,062,210 |
Apr 02 2020 | AQST | Aquestive Therapeutics, I ... | Schobel Alexander Mark | Chief Innovation/Tech ... | Sell | 2.19 | 97 | 212 | 1,062,113 |
Apr 02 2020 | AQST | Aquestive Therapeutics, I ... | Schobel Alexander Mark | Chief Innovation/Tech ... | Option Exercise | 0.00 | 329 | 0 | 333 |
Mar 18 2020 | AQST | Aquestive Therapeutics, I ... | Schobel Alexander Mark | Chief Innovation/Tech ... | Option Exercise | 1.54 | 70,000 | 107,800 | 70,000 |
Mar 18 2020 | AQST | Aquestive Therapeutics, I ... | Schobel Alexander Mark | Chief Innovation/Tech ... | Option Exercise | 1.54 | 70,000 | 107,800 | 70,000 |
Mar 03 2020 | AQST | Aquestive Therapeutics, I ... | Schobel Alexander Mark | Chief Innovation/Tech ... | Buy | 0.00 | 14,572 | 0 | 1,066,947 |
Mar 03 2020 | AQST | Aquestive Therapeutics, I ... | Schobel Alexander Mark | Chief Innovation/Tech ... | Sell | 3.73 | 5,066 | 18,896 | 1,061,881 |
Mar 03 2020 | AQST | Aquestive Therapeutics, I ... | Schobel Alexander Mark | Chief Innovation/Tech ... | Option Exercise | 0.00 | 14,572 | 0 | 14,572 |
Dec 02 2019 | AQST | Aquestive Therapeutics, I ... | Schobel Alexander Mark | Chief Innovation/Tech ... | Buy | 0.00 | 14,572 | 0 | 1,058,737 |
Dec 02 2019 | AQST | Aquestive Therapeutics, I ... | Schobel Alexander Mark | Chief Innovation/Tech ... | Sell | 7.79 | 14,572 | 113,516 | 1,044,165 |
Dec 02 2019 | AQST | Aquestive Therapeutics, I ... | Schobel Alexander Mark | Chief Innovation/Tech ... | Option Exercise | 0.00 | 14,572 | 0 | 29,144 |
Oct 02 2019 | AQST | Aquestive Therapeutics, I ... | Schobel Alexander Mark | Chief Innovation/Tech ... | Buy | 0.00 | 329 | 0 | 1,044,310 |
Oct 02 2019 | AQST | Aquestive Therapeutics, I ... | Schobel Alexander Mark | Chief Innovation/Tech ... | Sell | 3.18 | 145 | 461 | 1,044,165 |
Oct 02 2019 | AQST | Aquestive Therapeutics, I ... | Schobel Alexander Mark | Chief Innovation/Tech ... | Option Exercise | 0.00 | 329 | 0 | 991 |
Sep 03 2019 | AQST | Aquestive Therapeutics, I ... | Schobel Alexander Mark | Chief Innovation/Tech ... | Buy | 0.00 | 14,572 | 0 | 1,050,441 |
Sep 03 2019 | AQST | Aquestive Therapeutics, I ... | Schobel Alexander Mark | Chief Innovation/Tech ... | Sell | 3.80 | 6,460 | 24,548 | 1,043,981 |
Sep 03 2019 | AQST | Aquestive Therapeutics, I ... | Schobel Alexander Mark | Chief Innovation/Tech ... | Option Exercise | 0.00 | 14,572 | 0 | 43,716 |
Jul 02 2019 | AQST | Aquestive Therapeutics, I ... | Schobel Alexander Mark | Chief Innovation/Tech ... | Buy | 0.00 | 329 | 0 | 1,036,018 |
Jul 02 2019 | AQST | Aquestive Therapeutics, I ... | Schobel Alexander Mark | Chief Innovation/Tech ... | Buy | 0.00 | 329 | 0 | 1,036,018 |
Jul 02 2019 | AQST | Aquestive Therapeutics, I ... | Schobel Alexander Mark | Chief Innovation/Tech ... | Sell | 4.20 | 149 | 626 | 1,035,869 |
Jul 02 2019 | AQST | Aquestive Therapeutics, I ... | Schobel Alexander Mark | Chief Innovation/Tech ... | Sell | 4.20 | 149 | 626 | 1,035,869 |
Jul 02 2019 | AQST | Aquestive Therapeutics, I ... | Schobel Alexander Mark | Chief Innovation/Tech ... | Option Exercise | 0.00 | 329 | 0 | 1,320 |
Jul 02 2019 | AQST | Aquestive Therapeutics, I ... | Schobel Alexander Mark | Chief Innovation/Tech ... | Option Exercise | 0.00 | 329 | 0 | 1,320 |
Jun 03 2019 | AQST | Aquestive Therapeutics, I ... | Schobel Alexander Mark | Chief Innovation/Tech ... | Buy | 0.00 | 14,572 | 0 | 1,042,280 |
Jun 03 2019 | AQST | Aquestive Therapeutics, I ... | Schobel Alexander Mark | Chief Innovation/Tech ... | Sell | 3.72 | 6,591 | 24,519 | 1,035,689 |
Jun 03 2019 | AQST | Aquestive Therapeutics, I ... | Schobel Alexander Mark | Chief Innovation/Tech ... | Option Exercise | 0.00 | 14,572 | 0 | 58,288 |
Apr 01 2019 | AQST | Aquestive Therapeutics, I ... | Schobel Alexander Mark | Chief Innovation/Tech ... | Buy | 0.00 | 329 | 0 | 1,027,971 |
Apr 01 2019 | AQST | Aquestive Therapeutics, I ... | Schobel Alexander Mark | Chief Innovation/Tech ... | Sell | 6.91 | 263 | 1,817 | 1,027,708 |
Apr 01 2019 | AQST | Aquestive Therapeutics, I ... | Schobel Alexander Mark | Chief Innovation/Tech ... | Option Exercise | 0.00 | 329 | 0 | 1,649 |
Mar 04 2019 | AQST | Aquestive Therapeutics, I ... | Schobel Alexander Mark | SVP,Chief Innov/Tech ... | Option Exercise | 8.05 | 75,000 | 603,750 | 75,000 |
Mar 01 2019 | AQST | Aquestive Therapeutics, I ... | Schobel Alexander Mark | Chief Innovation/Tech ... | Buy | 0.00 | 14,572 | 0 | 1,034,363 |
Mar 01 2019 | AQST | Aquestive Therapeutics, I ... | Schobel Alexander Mark | Chief Innovation/Tech ... | Sell | 8.05 | 6,721 | 54,104 | 1,027,642 |
Mar 01 2019 | AQST | Aquestive Therapeutics, I ... | Schobel Alexander Mark | Chief Innovation/Tech ... | Option Exercise | 0.00 | 14,572 | 0 | 72,860 |
Jan 03 2019 | AQST | Aquestive Therapeutics, I ... | Schobel Alexander Mark | Chief Innovation/Tech ... | Buy | 0.00 | 329 | 0 | 1,019,953 |
Jan 03 2019 | AQST | Aquestive Therapeutics, I ... | Schobel Alexander Mark | Chief Innovation/Tech ... | Sell | 6.30 | 162 | 1,021 | 1,019,791 |
Jan 03 2019 | AQST | Aquestive Therapeutics, I ... | Schobel Alexander Mark | Chief Innovation/Tech ... | Option Exercise | 0.00 | 329 | 0 | 1,978 |
Dec 11 2018 | AQST | Aquestive Therapeutics, I ... | Schobel Alexander Mark | Chief Innovation/Tech ... | Buy | 7.78 | 1,000 | 7,780 | 1,019,624 |
Dec 10 2018 | AQST | Aquestive Therapeutics, I ... | Schobel Alexander Mark | Chief Innovation/Tech ... | Buy | 8.69 | 2,000 | 17,380 | 1,018,624 |
Dec 04 2018 | AQST | Aquestive Therapeutics, I ... | Schobel Alexander Mark | Chief Innovation/Tech ... | Buy | 0.00 | 14,572 | 0 | 1,023,801 |
Dec 04 2018 | AQST | Aquestive Therapeutics, I ... | Schobel Alexander Mark | Chief Innovation/Tech ... | Sell | 8.59 | 7,177 | 61,650 | 1,016,624 |
Dec 04 2018 | AQST | Aquestive Therapeutics, I ... | Schobel Alexander Mark | Chief Innovation/Tech ... | Option Exercise | 0.00 | 14,572 | 0 | 87,432 |
Nov 26 2018 | AQST | Aquestive Therapeutics, I ... | Schobel Alexander Mark | Chief Innovation/Tech ... | Buy | 10.25 | 1,000 | 10,250 | 1,009,229 |
Oct 02 2018 | AQST | Aquestive Therapeutics, I ... | Schobel Alexander Mark | Chief Innovation/Tech ... | Buy | 0.00 | 329 | 0 | 1,008,391 |
Oct 02 2018 | AQST | Aquestive Therapeutics, I ... | Schobel Alexander Mark | Chief Innovation/Tech ... | Sell | 17.51 | 162 | 2,837 | 1,008,229 |
Oct 02 2018 | AQST | Aquestive Therapeutics, I ... | Schobel Alexander Mark | Chief Innovation/Tech ... | Option Exercise | 0.00 | 329 | 0 | 2,307 |
Sep 05 2018 | AQST | Aquestive Therapeutics, I ... | Schobel Alexander Mark | Chief Innovation/Tech ... | Buy | 0.00 | 14,572 | 0 | 1,014,572 |
Sep 05 2018 | AQST | Aquestive Therapeutics, I ... | Schobel Alexander Mark | Chief Innovation/Tech ... | Sell | 18.01 | 6,510 | 117,245 | 1,008,062 |
Sep 05 2018 | AQST | Aquestive Therapeutics, I ... | Schobel Alexander Mark | Chief Innovation/Tech ... | Option Exercise | 0.00 | 14,572 | 0 | 102,004 |
Aug 17 2018 | AQST | Aquestive Therapeutics, I ... | Schobel Alexander Mark | Chief Innovation/Tech ... | Option Exercise | 16.46 | 28,043 | 461,588 | 28,043 |
Aug 17 2018 | AQST | Aquestive Therapeutics, I ... | Schobel Alexander Mark | Chief Innovation/Tech ... | Option Exercise | 0.00 | 2,636 | 0 | 2,636 |
Jul 26 2018 | AQST | Aquestive Therapeutics, I ... | Schobel Alexander Mark | Chief Innovation/Tech ... | Option Exercise | 15.00 | 240,165 | 3,602,475 | 240,165 |
Jul 26 2018 | AQST | Aquestive Therapeutics, I ... | Schobel Alexander Mark | Chief Innovation/Tech ... | Option Exercise | 0.00 | 116,576 | 0 | 116,576 |